Although the mechanism underlying eIF5A and HIF-1α expression is yet to be elucidated, this regulation makes eIF5A an attractive therapeutic target because HIF-1α mediates the adaptive response in the hypoxic environment of tumor spheroids [119,123]. The gene discussed is HIF1A; the disease is neoplasm.